Mangoceuticals, Other Operating Expenses vs Net Income Analysis
| MGRX Stock | 2.50 0.03 1.19% |
Mangoceuticals, Common financial indicator trend analysis is infinitely more than just investigating Mangoceuticals, Common recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mangoceuticals, Common is a good investment. Please check the relationship between Mangoceuticals, Common Other Operating Expenses and its Net Income accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mangoceuticals, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Other Operating Expenses vs Net Income
Other Operating Expenses vs Net Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mangoceuticals, Common Other Operating Expenses account and Net Income. At this time, the significance of the direction appears to have pay attention.
The correlation between Mangoceuticals, Common's Other Operating Expenses and Net Income is -1.0. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Net Income in the same time period over historical financial statements of Mangoceuticals, Common Stock, assuming nothing else is changed. The correlation between historical values of Mangoceuticals, Common's Other Operating Expenses and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Mangoceuticals, Common Stock are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Other Operating Expenses i.e., Mangoceuticals, Common's Other Operating Expenses and Net Income go up and down completely randomly.
Correlation Coefficient | -1.0 |
| Relationship Direction | Negative |
| Relationship Strength | Strong |
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Mangoceuticals, Common. It is also known as Mangoceuticals, Common overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Mangoceuticals, Common financial statement analysis. It represents the amount of money remaining after all of Mangoceuticals, Common Stock operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most indicators from Mangoceuticals, Common's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mangoceuticals, Common current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mangoceuticals, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. Selling General Administrative is likely to rise to about 6.8 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 4.1 M in 2024.
| 2010 | 2023 | 2024 (projected) | Gross Profit | 4.9K | 431.5K | 240.0K | Total Revenue | 8.9K | 731.5K | 407.2K |
Mangoceuticals, Common fundamental ratios Correlations
Click cells to compare fundamentals
Mangoceuticals, Common Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Mangoceuticals, Stock Analysis
When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.